Built with insights from the likes of AbbVie, Sanofi, Amgen and Takeda; CDD for Biologics has been specifically designed to help biopharma companies define strategies to further adapt computational tools, mitigate data availability issues and address computational-experimental challenges to add immediate value to their biologics pipelines.
This dedicated platform will enable you to address key challenges such as those of widespread data sharing, the experimental constraints of generating enough data and the importance of overcoming data silo-ing with organizations, as well as exploring new opportunities including a novel, AI-derived approach, an automated high-throughput engineering platform, successfully deploying ML algorithms and more.
Time: 08:00 to 17:00
Digital Attendance - Drug Developer - Conference Only: USD 1979.00,
Digital Attendance - Service Provider - Conference Only: USD 2579.00,
Digital Attendance - Academic - Conference Only: USD 1279.00
Speakers: Chris Roberts Professor - Chemical and Biomolecular Engineering University of Delaware, Maria Wendt Head of Biologics Research Sanofi, Nicolas Angell Director - Process Development and Pre-Pivotal Attribute Sciences Amgen, Rafael Depetris Principal Scientist and Structure Based Drug Design Lead Kadmon Corporation, Monica Wang Principal Engineer, Bioinformatics Architect, Project Program Management and Global Information Technology Lead Takeda Pharmaceutical, Andrew Urick Senior Scientist Abbvie, Brandon DeKoskyAssistant Professor - Chemical Engineering and Pharmaceutical ChemistryUniversity of Kansas, Claire Marks Research Software EngineerUniversity of Oxford, Dea Shahinas CEODeep Biologics, and many more!